Pathstone Holdings
KRYS icon

Pathstone Holdings’s Krystal Biotech KRYS Stock Holding History

Pathstone Holdings’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$579K Sell
2,241
-40
-2% -$10.6K ﹤0.01% 1684
2025
Q4 		$562K Sell
2,281
-2,066
-48% -$435K ﹤0.01% 1702
2025
Q3 		$767K Buy
4,347
+408
+10% +$61.1K ﹤0.01% 1559
2025
Q2 		$541K Sell
3,939
-4,170
-51% -$613K ﹤0.01% 1689
2025
Q1 		$1.46M Buy
8,109
+3,857
+91% +$649K 0.01% 1154
2024
Q4 		$666K Sell
4,252
-795
-16% -$141K ﹤0.01% 1595
2024
Q3 		$919K Buy
+5,047
New +$973K ﹤0.01% 1414

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return